WallStreetZenWallStreetZen

NASDAQ: ABEO
Abeona Therapeutics Inc Stock Ownership - Who owns Abeona Therapeutics?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Abeona Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Joseph Walter VazzanoChief Financial Officer2024-03-15703$8.14
$5.72kSell
Brendan M. OmalleySVP General Counsel2024-03-04183$7.81
$1.43kSell
Vishwas SeshadriChief Executive Officer2024-02-0620,000$4.39
$87.80kBuy
Mark AlvinoDirector2024-01-177,084$5.11
$36.20kSell
Vishwas SeshadriChief Executive Officer2023-10-16181$4.14
$749.34Sell
Joseph Walter VazzanoChief Financial Officer2023-09-296,230$3.93
$24.48kSell
Brendan M. OmalleySVP General Counsel2023-09-296,557$3.93
$25.77kSell
Vishwas SeshadriChief Executive Officer2023-09-2913,290$3.93
$52.23kSell
Faith L. CharlesDirector2023-09-278,330$4.91
$40.93kSell
Leila AllandDirector2023-09-277,246$3.90
$28.27kSell

1 of 3

ABEO insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ABEO insiders and whales buy or sell their stock.

ABEO Shareholders

What type of owners hold Abeona Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Sco Capital Partners LLC52.60%14,390,007$49.07MInsider
Steven H. Rouhandeh51.10%13,977,076$47.66MInsider
Adage Capital Partners GP LLC11.88%3,249,994$11.08MInsider
Adage Capital Partners GP LLC11.88%3,249,994$11.08MInstitution
Ayer Capital Management LP8.82%2,413,163$8.23MInsider
Nantahala Capital Management LLC8.23%2,250,252$7.67MInstitution
B. Davis Jeffrey7.04%1,926,170$6.57MInsider
Millennium Management LLC5.19%1,418,675$4.84MInstitution
Vanguard Group Inc4.03%1,101,131$3.75MInstitution
Oracle Associates LLC3.29%900,400$3.07MInsider

1 of 3

ABEO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ABEO25.76%74.24%Net BuyingNet Buying
SLS6.21%13.47%Net Selling
PMVP62.78%37.22%Net Buying
CRIS3.46%96.54%
QTTB47.15%52.85%Net SellingNet Selling
View Top Biotech Stocks

Abeona Therapeutics Stock Ownership FAQ

Who owns Abeona Therapeutics?

Abeona Therapeutics (NASDAQ: ABEO) is owned by 51.69% institutional shareholders, 149.00% Abeona Therapeutics insiders, and 0.00% retail investors. Sco Capital Partners LLC is the largest individual Abeona Therapeutics shareholder, owning 14.39M shares representing 52.60% of the company. Sco Capital Partners LLC's Abeona Therapeutics shares are currently valued at $45.62M.

If you're new to stock investing, here's how to buy Abeona Therapeutics stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.